NO942653L - Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient - Google Patents

Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient

Info

Publication number
NO942653L
NO942653L NO942653A NO942653A NO942653L NO 942653 L NO942653 L NO 942653L NO 942653 A NO942653 A NO 942653A NO 942653 A NO942653 A NO 942653A NO 942653 L NO942653 L NO 942653L
Authority
NO
Norway
Prior art keywords
patient
carcinoma
biological potential
estimating
assessing
Prior art date
Application number
NO942653A
Other languages
English (en)
Norwegian (no)
Other versions
NO942653D0 (no
Inventor
Michael K Brawer
Original Assignee
Michael K Brawer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael K Brawer filed Critical Michael K Brawer
Publication of NO942653D0 publication Critical patent/NO942653D0/no
Publication of NO942653L publication Critical patent/NO942653L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO942653A 1992-01-15 1994-07-14 Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient NO942653L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82112092A 1992-01-15 1992-01-15
PCT/US1993/000449 WO1993014407A1 (en) 1992-01-15 1993-01-15 A method for estimating the biologic potential of a selected carcinoma in a patient

Publications (2)

Publication Number Publication Date
NO942653D0 NO942653D0 (no) 1994-07-14
NO942653L true NO942653L (no) 1994-09-12

Family

ID=25232578

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942653A NO942653L (no) 1992-01-15 1994-07-14 Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient

Country Status (11)

Country Link
US (2) US5688694A (de)
EP (1) EP0643839B1 (de)
JP (1) JPH07503069A (de)
AT (1) ATE145728T1 (de)
AU (1) AU673153B2 (de)
CA (1) CA2128031A1 (de)
DE (1) DE69306250T2 (de)
ES (1) ES2095038T3 (de)
FI (1) FI943355A7 (de)
NO (1) NO942653L (de)
WO (1) WO1993014407A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1158047B1 (de) * 1999-03-05 2009-05-20 Mitsubishi Rayon Co., Ltd. Microarray mit einer biologischen substanz
US6730313B2 (en) * 2000-01-25 2004-05-04 Edwards Lifesciences Corporation Delivery systems for periadventitial delivery for treatment of restenosis and anastomotic intimal hyperplasia
WO2002037103A2 (en) 2000-11-06 2002-05-10 Board Of Regents, The University Of Texas System Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors
US6993175B2 (en) * 2001-09-07 2006-01-31 Quest Diagnostics Investments Incorporated Methods for measuring microvascular density in tumors
US7229423B2 (en) * 2003-02-05 2007-06-12 Timi 3 System, Inc Systems and methods for applying audible acoustic energy to increase tissue perfusion and/or vasodilation
US20070100335A1 (en) * 2005-10-28 2007-05-03 Apple Medical Corporation Instrument for electrosurgical excision procedure for the uterine cervix
US8321010B2 (en) * 2009-09-04 2012-11-27 Konstantin Georgievich Korotkov Method for determining the condition of a biological object and device for making same
FR2964744B1 (fr) * 2010-09-10 2015-04-03 Univ Versailles St Quentin En Yvelines Test pronostic de l'evolution d'une tumeur solide par analyse d'images

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06502177A (ja) * 1990-10-16 1994-03-10 バイオメディカル・フロンティアーズ・インコーポレイテッド 磁気共鳴映像用ポリマー−デフェロキサミン−第２鉄付加物

Also Published As

Publication number Publication date
EP0643839B1 (de) 1996-11-27
ES2095038T3 (es) 1997-02-01
DE69306250D1 (de) 1997-01-09
CA2128031A1 (en) 1993-07-22
US5688694A (en) 1997-11-18
AU673153B2 (en) 1996-10-31
AU3478293A (en) 1993-08-03
ATE145728T1 (de) 1996-12-15
JPH07503069A (ja) 1995-03-30
EP0643839A1 (de) 1995-03-22
FI943355A0 (fi) 1994-07-14
WO1993014407A1 (en) 1993-07-22
FI943355L (fi) 1994-09-14
FI943355A7 (fi) 1994-09-14
DE69306250T2 (de) 1997-03-20
US5616469A (en) 1997-04-01
NO942653D0 (no) 1994-07-14

Similar Documents

Publication Publication Date Title
Paulson et al. Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study
Witjes et al. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non–muscle-invasive bladder cancer: review of the evidence and recommendations
Catalona et al. Staging errors in clinically localized prostatic cancer
Loftus‐Hills et al. Reinforcement and reproductive character displacement in Gastrophryne carolinensis and G. olivacea (Anura: Microhylidae): a reexamination
Payne et al. A novel automated peak frequency annotation algorithm for identifying deceleration zones and ventricular tachycardia ablation sites
Yano et al. The subxiphoid approach leads to less invasive thoracoscopic thymectomy than the lateral approach
Inabnet Intraoperative parathyroid hormone monitoring
Estrade et al. Toward improved endoscopic examination of urinary stones: a concordance study between endoscopic digital pictures vs microscopy
Patel et al. Should we be doing routine biopsy after heart transplantation in a new era of anti-rejection?
DE69623264D1 (de) Verfahren zur diagnose gutartiger prostataerkrankungen
DE69906992D1 (de) Zweite medizinische indikation einer partikelverabreichungsmethode
ATE256992T1 (de) Ultraschallsonde mit einer lösbaren nadelführung zur gewebeprobeentnahme
DK0796424T3 (da) Fremgangsmåde til at opnå information
Young et al. Permanent section margin concordance after Mohs micrographic surgery with immunohistochemistry for invasive melanoma and melanoma in situ: a retrospective dual-center analysis
AU2001263992A1 (en) Method for in vitro diagnosis of prostatic cancer and kit therefor
AU1260399A (en) Method for examining kidney diseases
NO942653D0 (no) Fremgangsmåte for å anslå det biologiske potensialet til en valgt carsinoma hos en pasient
AU4623599A (en) Method for diagnosing an adenocarcinoma or a benign prostate pathology
CY1106073T1 (el) Φασματογραφια μαγνητικου συντονισμου βιοψιας μαστου για τον προσδιορισμο της παθολογιας, της αγγειωσεως και της εμπλοκης οζιδιων
FR2810114B1 (fr) Methode, procede, test immunologique et kit de diagnostic d'un adenocarcinome de la prostate ou d'une hypertrophie benigne de la prostate
Hutter et al. Subxiphoidal videomediastinoscopy for diagnostic access to the anterior mediastinum
Vo-Dinh Principle of synchronous luminescence (SL) technique for biomedical diagnostics
Reintgen Melanoma nodal metastases: biologic significance and therapeutic considerations
Shkolyar et al. Optical biopsy of penile cancer with in vivo confocal laser endomicroscopy
IL100527A0 (en) Prescreening of prostate cancer by serum prostatic specific antigen